• Refine Query
  • Source
  • Publication year
  • to
  • Language
  • 47
  • 37
  • 8
  • 7
  • 3
  • 3
  • 2
  • 1
  • Tagged with
  • 119
  • 119
  • 55
  • 29
  • 14
  • 13
  • 13
  • 13
  • 10
  • 10
  • 10
  • 9
  • 9
  • 9
  • 9
  • About
  • The Global ETD Search service is a free service for researchers to find electronic theses and dissertations. This service is provided by the Networked Digital Library of Theses and Dissertations.
    Our metadata is collected from universities around the world. If you manage a university/consortium/country archive and want to be added, details can be found on the NDLTD website.
71

Estudo da inibição aguda da heme oxigenase em ratos Wistar submetidos a restrição ou sobrecarga crônica de cloreto de sódio / Study of the effect of heme oxigenase inhibition in Wistar rats on low- or high-salt intake

Santos, Elisabete Alcantara dos 17 February 1998 (has links)
Heme oxigenase (HEOX) é uma enzima que converte o anel heme em biliverdina, monóxido de carbono (CO) e Fe3+. O CO ativa a guanilil ciclase, com resultante produção de 3?,5?-monofosfato de guanosina cíclico(cGMP) provocando relaxamento da musculatura lisa vascular. Nós verificamos o efeito da inibição aguda da heme oxigenase com zinco protoporfirina (ZnPP IX) sobre a pressão arterial de ratos Wistar machos recebendo dieta hipossódica (0,15% de NaCl), normossódica (1,3% de NaCl) ou hipersódica (8% de NaCl) desde o desmame, com 21 dias de vida. Para isto a pressão arterial caudal (grupo A - 3 e B - 6 meses de idade) e carotídea (grupo C) foram medidas antes e após a administração do inibidor da HEOX ou de veículo (Na2CO3). Em resposta ao ZnPP IX, os animais do grupo A submetidos à sobrecarga salina apresentaram uma significativa diminuição dos níveis pressóricos enquanto que os animais que recebiam dieta hipo e normossódica, apresentaram aumento dos níveis pressóricos. No grupo B e C, após inibição da enzima, não houve modificação dos níveis pressóricos dos ratos em nenhuma das três dietas. Observamos nos três grupos (A, B e C) uma correlação negativa entre a pressão arterial basal (antes da administração de ZnPP) e a área debaixo da curva da variação percentual das pressões arteriais após inibição de HEOX (grupo A: r = 0,66 - P < 0,0001?; grupo B: r = 0,59 - P = 0,006;?; grupo C: r = 0,59 - P < 0,0005?). Nos animais que receberam veículo, esta correlação não ocorreu, exceto para PAS no grupo C. Podemos concluir que a resposta pressórica à inibição da HEOX é modulada pela pressão arterial basal. / The heme ring is hydrolyzed by an enzyme called heme oxygenase (HEOX). The products of that reaction are biliverdin, carbon monoxide (CO) and Fe3+. CO produces vascular smooth muscle cell relaxation due to activation of guanylyl ciclase with the resultant production of 3?,5?-ciclic guanosine monophosphate (cGMP). In the present study the effect on blood pressure due to acute inhibition of HEOX by zinc protoporphyrin IX (ZnPP IX) was observed. Male Wistar rats were fed low (LSD ? 0.15% NaCl), normal (NSD ? 1.3%) or high salt diet (HSD - 8% NaCl) from weaning (21 days-old animals). Tail-cuff blood pressure was measured in group A and B and continuous intra-arterial pressure was evaluated in group C before and after ZnPP IX or vehicle (Na2CO3) administration. In group A, blood pressure decreased in rats on HSD, and increased in the animals on NSD and LSD after ZnPP IX administration. A similar response to ZnPP IX was observed in group B. In group C no change in blood pressure was observed in the rats on the three diets. A negative correlation was obtained between blood pressure measured before ZnPP IX and the area under the curve of the percentual blood pressure change induced by ZnPP IX [(group A: r=0.66 - P<0.0001), (group B: r=0.59 - P=0.006), and (group C: r=0.59 - P<0.0005)]. In the animals that received vehicle, this correlation was not observed. In conclusion, in Wistar rats, the effect of HEOX inhibition by ZnPP IX is modulated by the basal blood pressure levels.
72

Papel da Heme Oxigenase 1 na modulação da inflamação pulmonar causada pela isquemia e reperfusão intestinal em ratos. / Role of Heme Oxigenase 1 on the lung inflammation induced by intestinal ischemia and reperfusion in rats.

Jônatas de Almeida Bertoni 07 February 2013 (has links)
Evidências clínicas e experimentais mostram que a isquemia e reperfusão intestinal (I/R-intestinal) induz lesão pulmonar aguda (LPA) que, em casos mais graves, pode evoluir para a síndrome do desconforto respiratório agudo (SDRA). A LPA se caracteriza pela liberação de amplo espectro de mediadores inflamatórios, infiltração de neutrófilos e aumento de permeabilidade vascular. Sabe-se que mediadores inflamatórios gerados no local da I/R-intestinal são transportados pelo sistema linfático mesentérico e, ao atingirem o pulmão, contribuem para a LPA. A enzima heme oxigenase 1 (HO-1), exerce importante função na homeostasia celular, devido à sua ação catabólica sobre o grupo heme das hemoproteínas, gerando como subprodutos ferro, biliverdina e monóxido de carbono. Esses subprodutos possuem ação antiinflamatória, antioxidante e antiapoptótica. Todavia, o papel da HO-1 no controle da LPA causada pela I/R-intestinal ainda não está totalmente esclarecido. No presente estudo investigamos a expressão da HO-1 e o efeito de sua indução sobre as repercussões pulmonares decorrentes da I/R-intestinal. Para tanto, ratos machos Wistar (220-250 g) foram submetidos a 45 min de isquemia intestinal pela obstrução da artéria mesentérica superior e a 2 h de reperfusão. O grupo controle consistiu de animais falsamente operados (Sham). Ainda, a indução da HO-1 foi realizada pelo tratamento dos animais com o composto Hemin (10 mg/kg) 48 e 24 h antes da indução da I/R-intestinal. A I/R-intestinal aumentou a atividade pulmonar da mieloperoxidase (MPO) e o extravasamento do corante azul de Evans (AE) no pulmão. Os níveis de IL-1<font face=\"Symbol\">b elevaram no explante pulmonar (24 h) enquanto os de IL-10 foram reduzidos após a I/R-intestinal. Ainda, a I/R-intestinal diminui a expressão pulmonar da SOD-1 e promoveu aumento da expressão da iNOS. Os resultados obtidos revelam que a I/R-intestinal por si só não induziu a expressão gênica da enzima HO-1, porém o tratamento dos animais com Hemin elevou a sua expressão, a qual foi acompanhada pela redução da atividade pulmonar de MPO e do extravasamento do corante AE. Os elevados níveis pulmonares de IL-1<font face=\"Symbol\">b foram reduzidos pelo tratamento dos animais com o Hemin e houve elevação da IL-10 e VEGF no mesmo tecidos. A indução da HO-1 preveniu o aumento dos níveis de IL-1<font face=\"Symbol\">b e IL-10 e promoveu aumento dos níveis de VEGF na linfa dos animais. Com respeito ao sistema antioxidante, nossos dados indicaram que a indução da HO-1, parece estar relacionada com a elevação da expressão de SOD-1, SOD-2 e redução da expressão de iNOS. Concluindo, os dados obtidos permitem sugerir que a indução prévia da expressão de HO-1 controla a magnitude da lesão pulmonar causada pela I/R-intestinal por mecanismos envolvendo o aumento da atividade de parcela do sistema antioxidante e regulação do balanço entre a geração de citocinas antiinflamatórias e pró-inflamatórias no pulmão. / Clinical and experimental evidences have reported that intestinal ischemia and reperfusion (I/R-intestinal) induces acute lung injury (ALI), which in severe cases can progress to acute respiratory distress syndrome (ARDS). The ALI is characterized by the release of a broad spectrum of inflammatory mediators, neutrophil infiltration and increased vascular permeability. It is known that inflammatory mediators generated at the site of I/R-intestinal are transported by the mesenteric lymphatic system and, on reaching the lung, contribute to the ALI. The enzyme heme oxygenase 1 (HO-1) plays an important role in cellular homeostasis, due to its catabolic action on heme group of hemoproteins, forming as by-products such as iron, biliverdin and carbon monoxide. It is known that these by-products have anti-inflammatory, antioxidant and antiapoptotic actions. However, the role of HO-1 in the control of ALI caused by I/R-intestinal is not yet fully understood. In the present study we investigated the expression of HO-1 and the effects of its induction on pulmonary complications resulting from I/R-intestinal. So, male Wistar rats (220-250 g) were subjected to 45 min of intestinal ischemia by occlusion of the superior mesenteric artery and 2 h of reperfusion. The control group consisted of animals falsely operated (Sham). Still, the induction of HO-1 was performed by treating animals with the compound Hemin (10 mg/kg) 48 and 24 h before the induction of I/R-intestinal. The I/R-intestinal increased the pulmonary activity of the myeloperoxidase (MPO) and the extravasation of Evans blue dye (EB) in the lung. Levels of IL-1<font face=\"Symbol\">b increased in lung explant (24 h) while the IL-10 were reduced after I/R-intestinal. Further, the I/R-intestinal reduces pulmonary expression of SOD-1 and promoted the increase of iNOS expression. The results indicate that the I/R-intestinal alone did not induce gene expression of HO-1 enzyme, but the treatment of animals with Hemin increased its expression which was accompanied by reduction of pulmonary activity of MPO and extravasation of the dye EB. The high pulmonary levels of IL-1 were reduced by treatment of animals with Hemin and there was an increase of IL-10 and VEGF in the same tissue. The Induction of HO-1 prevented the increased levels of IL-<font face=\"Symbol\">b 1 and IL-10 and promoted increasing of the VEGF levels in the animals lymph. With respect to the antioxidant system, our data indicate that induction of HO-1, seems to be related to the elevation of expression of SOD-1, SOD-2 and reduction of iNOS expression. In conclusion, our data may suggest that prior induction of HO-1 expression controls the magnitude of lung injury caused by I/R-intestinal by mechanisms involving increased activity of a portion of the antioxidant system and regulation of the balance between generation anti-inflammatory cytokines and pro-inflammatory in the lung.
73

Papel da heme-oxigenase na proteção pelas estatinas na insuficiência renal aguda isquêmica em ratos. / Role os heme-oxygenase in the protection of statin in ischemic acute renal failure in rats.

Claudia Akemi Shibuya 31 July 2006 (has links)
O inibidor de HMG redutase (estatina) pode ter papel protetor na função renal por estimulação da atividade de HO-1. Este estudo foi desenvolvido para avaliar se a associação desses dois agentes poderia induzir um efeito mais pronunciado sobre a função renal (FR) após insuficiência renal aguda isquêmica. A isquemia foi obtida por meio do clampeamento dos pedículos renais bilaterais por 30 minutos, seguida de reperfusão. Foram utilizados ratos wistar, machos, pesando entre 250-300g, distribuídos nos grupos: SHAM (controle, sem clampeamento renal); Isquemia; Estatina (animais que receberam 0,5 mg/kg, via oral, v.o., por 3 dias); Iquemia+Estatina; Hemin (indutor de HO-1, 1 mg/100g, i.p., 24h antes da cirurgia); Isquemia+Hemin; SnPP (inibidor de HO-1, 2µmol/kg i.p. 24h antes da cirurgia); Isquemia+SnPP; Estatina+Hemin; Isquemia+Estatina+Hemin; Estatina+SnPP; Isquemia+Estatina+SnPP. Foram avaliados a função renal (FR) (clearance de creatinina, método Jaffé), a excreção de peróxidos urinário (FOX-2), a osmolalidade urinária (osmômetro) e a imunohistoquímica para ED-1. Os resultados mostraram que a estatina otimizou a FR e reduziu a excreção de peróxidos urinários. A indução da HO-1 apresentou padrão similar ao descrito para estatina. A associação de estatina+Hemin induziu melhora de FR, com melhora de função tubular e redução de peróxidos discretamente superior àquela demonstrada pelos tratamentos isolados. A substituição do Hemin pelo SnPP no modelo de associação não pareceu ter inibido o efeito da estatina. Em síntese, o estudo confirmou o efeito antioxidante da estatina e do Hemin com proteção da FR pelos métodos utilizados. Os resultados da imunohistoquímica ED-1 para macrófagos/monócitos não foram conclusivos. / HMG-CoA inhibition reductase (statins) can have a protector role on renal function by sitmulating HO-1 activity. This study was performed in order to evaluate if the association of these two agents could induce a more pronounced effect on RF after ischemic acute renal failure. The ischemia was obtained through clamping of bilateral renal pedicles for 30 minutes following by reperfusion. Adult Wistar rats, weighting from 250-300g, were divided into twelve groups: SHAM (control); Isch (30´renal ischemia); Stat (statin 0,5mg/kg, p.o.); Isch+Stat (statin 0.5mg/kg, p.o., once a day, 3 days and the Isch); Hemin (HO-1 inducer, hemin, 1.0mg/100g, i.p.); Isch+Hemin (HO-1 inducer, hemin, 1.0mg/100g, i.p., once, 24hours before Isch); SnPP (2µmol/kg, i.p.); Isch+SnPP (HO-1 inhibitor, 2?mol/kg, i.p., as hemin); Stat+Hemin; Isch+Stat+Hemin (all treatments as described); Stat+SnPP; Isch+Stat+SnPP (all treatments as described). Creatinin clearance (crCl), urinary peroxides (UP), osmolality (Osm) and immunohistochemical for ED-1 analyses were performed in order to evaluate oxidant and inflammatory responses.Results have shown that Stat could protect RF and peroxide excrection probably attenuating tubular damage. HO-1 presented a similar pattern to that described for statin. Instead, when Hemin or SnPP was associated to Statin, no benefit was observed neither to RF nor to UP. Imunohistochemical ED-1 for macrophages/monocytes analysis were inconclusive.
74

CaracterizaÃÃo estrutural preliminar e efeitos na inflamaÃÃo da lectina da alga marinha verde Caulerpa cupressoides / Structural characterization and preliminary effects on inflammation of the lectin of the green seaweed Caulerpa cupressoides

Ismael Nilo Lino de Queiroz 19 February 2013 (has links)
CoordenaÃÃo de AperfeiÃoamento de Pessoal de NÃvel Superior / As lectinas de algas marinhas possuem vÃrias aplicaÃÃes farmacolÃgicas. O objetivo deste trabalho foi caracterizar parcialmente a estrutura e avaliar os efeitos em modelos clÃssicos de inflamaÃÃo da lectina da alga marinha verde Caulerpa cupressoides. A lectina de Caulerpa cupressoides (LCc) foi extraÃda com tampÃo Tris-HCl 25 mM, pH 7,5 e isolada por cromatografia de troca iÃnica em coluna de DEAE-celulose. A caracterizaÃÃo estrutural parcial apresentou uma sequÃncia aminoterminal com 31 resÃduos de aminoÃcidos, obtida de acordo com o mÃtodo de degradaÃÃo de Edman, enquanto que na espectroscopia de ressonÃncia magnÃtica nuclear unidimensional 1H para a LCc purificada por Sephadex G-100 e obtida por DEAE-celulose, foi demostrado uma similaridade entre os sinais obtidos em ambos os espectros. A atividade anti-inflamatÃria foi avaliada em ratos Wistar machos (n=6), utilizando o modelo de edema de pata induzidos por carragenana (700 &#956;g/pata), dextrana (500 &#956;g/pata), histamina (100 &#956;g/pata), serotonina (20 &#956;g/pata) ou bradicinina (30 &#956;g/pata). Grupos de animais foram submetidos ao tratamento com LCc (0,1; 1,0 ou 10,0 mg/kg; i.v.), 30 min antes do estÃmulo inflamatÃrio. Foi avaliado o envolvimento da LCc (1,0 mg/kg) na via da Heme oxigenase-1. Foram utilizados grupos que receberam tratamento com LCc ligada ao inibidor mucina (8,0 mg/kg; i.v.) ou somente mucina (8,0 mg/kg; i.v.) e dexametasona (1,0 mg/kg; s.c.) foram utilizados como controles. O efeito edematogÃnico de LCc foi avaliado aplicando as doses de 0,1; 1,0 ou 10 mg/kg (i.pl.). No ensaio de edema de pata induzido por carragenana, LCc reduziu a formaÃÃo de edema sendo confirmado pela determinaÃÃo dos nÃveis teciduais de mieloperoxidase. A LCc (1,0 mg/kg) ligada a mucina nÃo apresentou efeito anti-inflamatÃrio no edema de pata induzido por carragenana, exceto na primeira hora apÃs o estÃmulo. No edema induzido por dextrana, LCc tambÃm inibiu o edema osmÃtico. Apenas a dose de 1,0 mg/kg foi utilizada no edema induzido por histamina reduzindo em 40% o edema no intervalo de 30 min LCc (1,0 mg/kg), entretanto, nÃo reduziu a formaÃÃo de edema induzido por serotonina ou bradicinina. AlÃm disso, na anÃlise histolÃgica do tecido subplantar, LCc (1,0 e 10,0 mg/kg) foi capaz de reduzir a migraÃÃo celular. Na presenÃa de ZnPP IX (3,0 mg/kg; s.c.), LCc perdeu sua capacidade inibir o edema induzido por carragenana, exercendo seu mecanismo de aÃÃo anti-inflamatÃrio atravÃs do envolvimento da via da HO-1. Enquanto que na imunohistoquÃmica, LCc (10 mg/kg) reduziu a expressÃo de IL-1&#946;, porÃm ocorreu intensa marcaÃÃo das citocinas TNF-&#945; e IL-6, alÃm da expressÃo de HO-1, nos grupos tratados com a mesma dose de LCc. Com relaÃÃo ao efeito edematogÃnico, LCc foi capaz de induzir intenso processo inflamatÃrio com efeito dose-dependente. No entanto, o edema induzido com a dose de 10 mg/kg de LCc foi foi inibido por indometacina, meclizina, pentoxifilina e dexametasona. Portanto, a LCc quando parcialmente caracterizada apresentou na sua sequÃncia aminoterminal uma identidade de 43% com a proteÃna da alga verde unicelular Chlamydomonas reinhardtii e apresentou propriedades anti- e prÃ-inflamatÃrias, sendo considerada um agente terapÃutico em potencial para estudos futuros nos processos inflamatÃrios. / Lectins seaweed have various pharmacological applications. This work was partially characterize the structure and evaluate the effects on classical models of inflammation lectin of the green seaweed Caulerpa cupressoides. The Caulerpa cupressoides lectin (CcL) was extracted with Tris-HCl 25 mM, pH 7.5 and isolated by ion exchange chromatography on DEAE-cellulose. Structural characterization showed a partial aminoterminal sequence with 31 amino acid residues, obtained according to the method of Edman degradation, while in nuclear magnetic resonance spectroscopy to the CcL 1H-NMR purified by Sephadex G-100 and DEAE-cellulose obtained by was demonstrated similarity between signals obtained in both spectra. The anti-inflammatory activity was evaluated in male Wistar rats (n = 6), using the model of paw edema induced by carrageenan (700 &#956;g/paw), dextran (500 &#956;g/paw), histamine (100 &#956;g/paw), serotonin (20 &#956;g/paw) or bradykinin (30 &#956;g/paw). Groups of animals were treated with CcL (0.1, 1.0 or 10.0 mg/kg, i.v.) 30 min before the inflammatory stimulus. Was evaluated the involvement of CcL (1.0 mg/kg) towards heme oxygenase-1. Groups were used that were treated with inhibitor CcL linked mucin (8.0 mg/kg, i.v.) or only mucin (8.0 mg/kg, i.v.) and dexamethasone (1.0 mg/kg, s.c.) were used as controls. The effect edematogenic CcL was evaluated by applying the doses of 0.1, 1.0 or 10 mg/kg (i.pl.). In the trial of paw edema induced by carrageenan, CcL reduced edema formation was confirmed by determining tissue levels of myeloperoxidase. CcL (1.0 mg/kg) showed no mucin linked to anti-inflammatory effect on the paw edema induced by carrageenan, except in the first hour after stimulation. In dextran-induced edema, CcL also inhibited the osmotic swelling. Only the dose of 1.0 mg/kg was used in reducing histamine-induced edema by 40% the edema within 30 min CcL (1.0 mg/kg), however, did not reduce the edema induced by serotonin or bradykinin. Besides, in the histological analysis of tissue subplantar, CcL (1.0 and 10.0 mg/kg) was able to reduce cell migration. In the presence of ZnPP IX (3.0 mg/kg, s.c.), CcL has lost its ability to inhibit the carrageenan-induced edema, exerting its mechanism of action anti-inflammatory pathway through the involvement of HO-1. While in immunohistochemistry, CcL (10 mg/kg) reduced the expression of IL-1&#946;, but intense staining occurred cytokines TNF-&#945; and IL-6, and expression of HO-1 in the groups treated with the same dose of CcL. In relation the effect edematogenic, CcL was able to induce intense inflammatory process with dose-dependent effect. However, the induced edema at a dose of 10 mg/kg was CcL was inhibited by indomethacin, meclizine, pentoxifylline and dexamethasone. Therefore, when the CcL partially characterized presented in its aminoterminal sequence of 43% identity with the protein from unicellular green alga Chlamydomonas reinhardtii and showed anti-and pro-inflammatory therapeutic agent is considered a potential for future studies in inflammatory processes.
75

Comparação de padrões de dieta vegetariana versus onívora sobre o efeito de ativação da via NRF2 em células endoteliais

Cinegaglia, Naiara da Costa. January 2019 (has links)
Orientador: Valéria Cristina Sandrim / Resumo: Evidências apontam que a dieta vegetariana diminui a probabilidade de desenvolver doenças cardiovasculares (DCVs). Um dos principais mecanismos que levam às doenças cardiovasculares é a disfunção do endotélio, associada com a diminuição da biodisponibilidade de óxido nítrico (NO) e a produção excessiva de espécies reativas de oxigênio (ROS). Do ponto de vista de biomarcadores de estresse oxidativo/antioxidante e de envelhecimento biológico, enzimas com propriedades antioxidantes e o comprimento do telômero podem apresentar efeitos na modulação do sistema vascular. O presente estudo inclui dois manuscritos, sendo o primeiro relacionado a via de regulação NRF2/HO-1 e o segundo ao comprimento dos telômero em onívoros (ONI) e vegetarianos (VEG). No primeiro manuscrito, o objetivo foi verificar a concentração de HO-1 circulante, bem como investigar o efeito da incubação do plasma de ONI e VEG em células endoteliais sob a modulação da via NRF2/HO-1 e a produção de NO. Dos 745 indivíduos inicialmente recrutados, 44 ONI e 44 VEG do sexo masculino aparentemente saudáveis foram incluídos no estudo. A concentração de HO-1 circulante foi mensurado usando o ensaio de ELISA. As células endoteliais foram incubadas com amostras de plasma de ONI e VEG. Nós observamos que a concentração de HO-1 circulante foi maior nos ONI em relação aos VEG. A incubação das células endoteliais com o plasma de ONI induziu o aumento da expressão gênica/proteica do NRF2 e HO-1, bem como a atividade do ARE e a pr... (Resumo completo, clicar acesso eletrônico abaixo) / Abstract: Several studies report that a vegetarian diet lowers the probability of developing cardiovascular diseases (CVDs). The endothelial dysfunction is one of the main mechanism that leads to CVDs, associated with decreased nitric oxide (NO) bioavailability and excessive production of reactive oxygen species (ROS). Regarding oxidative/antioxidant stress and biological aging biomarkers, enzymes with antioxidant properties and telomere length may have effects on vascular system modulation. The present study includes two manuscripts related to: 1) regulation of NRF2/HO-1 pathway and 2) telomere length in omnivorous (OMN) and vegetarians (VEG). In the first manuscript, our objectives were to verify circulating HO-1 levels and the effect of plasma incubation from omnivorous and vegetarians in endothelial cells on modulating of NRF2/HO-1 pathway and NO production. From 745 participants initially recruited, 44 omnivorous and 44 vegetarian men apparently healthy were included in this study and circulating HO-1 was measured using ELISA assay. Endothelial cells were incubated plasma samples from OMN and VEG. We found higher circulating HO-1 production in omnivorous compared to vegetarian. Moreover, the plasma collected from omnivorous was able to increase the gene/protein NRF2/HO-1 expression, ARE activity, and NO production in endothelial cells culture compared to vegetarian group. We suggest that HO-1 induction in omnivorous may indicate a pro-oxidative. Activation of the HO-1 / NRF2 pathw... (Complete abstract click electronic access below) / Doutor
76

Genetische Analyse der Hämoxygenase-1 bei verschiedenen Formen der Pankreatitis

Jesinghaus, Moritz 10 January 2014 (has links) (PDF)
Die Hämoxygenase-1 (HO-1) ist das geschwindigkeitsbestimmende Enzym des Hämabbaus und ist wichtiger Regulator inflammatorischer Prozesse. Der Verlauf einer experimentellen akuten Pankreatitis (AP) konnte im Tiermodell durch HO-1 Induktion abgemildert werden. Die Aktivierung und Proliferation pankreatischer Stellatum Zellen (PSC) wird durch eine experimentelle HO-1 Induktion inhibiert und kann so möglicherweise vor der Fibrosierung des Pankreasparenchyms bei chronischer Pankreatitis (CP) schützen. Die Transkription der HO-1 wird durch einen GT-Repeat beeinflusst, der im Promoter lokalisiert ist. Diese Arbeit untersuchte, ob Varianten des GT-Repeat oder weitere genetische Varianten der HO-1 mit verschiedenen Pankreatitisformen assoziiert sind. Der GT-Repeat und der SNP rs2071746 wurden mit fluoreszensmarkierten Primern bzw. mit Schmelzkurvenanalyse bei 285 Patienten mit AP, bei 208 Patienten mit alkoholischer CP (ACP), bei 207 mit idiopathischer/hereditärer CP (ICP/HCP), 147 Patienten mit Alkoholischer Leberzirrhose (ALZ) und bei 289 Kontrollen untersucht. Bei den ACP Patienten wurde die GT-Repeat Analyse auf insgesamt 446 Patienten erhöht. Zusätzlich wurden die kodierenden HO-1 Abschnitte mittels DNA-Sequenzierung bei 145 Patienten mit ACP, 138 Patienten mit ICP/HCP, 147 Patienten mit ALZ und bei 151 Kontrollen analysiert. Das Exon 3 wurde darüber hinaus bei zusätzlichen ICP/HP Patienten und Kontrollen untersucht. Die Längenverteilungen des GT-Repeat, die Allelverteilung des SNP rs2071746 und die Verteilung der bei der DNA-Sequenzierung gefundenen synonymen und nicht synonymen Varianten waren bei allen untersuchten Gruppen nicht signifikant unterschiedlich. Obwohl die funktionellen Daten einen Einfluss von HO-1 Varianten auf die Pathogenese der verschiedenen Pankreatitis-Formen nahelegen, konnte unsere umfangreiche genetische Analyse keine Assoziation nachweisen. Genetische Varianten der HO-1 haben keinen Einfluss auf die Entwicklung einer AP, ACP, ICP/HCP und ALZ.
77

NOS2 Induction and HO-­1-­Mediated Transcriptional Control in Gram-­Negative Peritonitis

Withers, Crystal Michele January 2013 (has links)
<p>Nitric oxide (NO) is an endogenous gaseous signaling molecule produced by three NO synthase isoforms (NOS1, 2, 3) and important in host defense. The induction of NOS2 during bacterial sepsis is critical for pathogen clearance but its sustained activation has long been associated with increased mortality secondary to multiple organ dysfunction syndrome (MODS). High levels of NO produced by NOS2 incite intrinsic cellular dysfunction, in part by damaging macromolecules through nitration and/or nitrosylation. These include mitochondrial DNA (mtDNA) and enzymes of key mitochondrial pathways required for maintenance of normal O2 utilization and energy homeostasis. However, animal studies and clinical trials inhibiting NOS2 have demonstrated pronounced organ dysfunction and increased mortality in response to live bacterial infections, confirming that NOS2 confers pro-survival benefits. Of particular interest here, the constitutive NOS1 and NOS3 have been linked to the up-regulation of nuclear genes involved in mitochondrial biogenesis but no comparable role has been described for NOS2. <italic> Therefore, I hypothesized that NOS2 is indispensible for host protection but must be tightly regulated to ensure NO levels are high enough to activate mitochondrial and other pro-survival genes, but below the threshold for cellular damage.</italic></p><p>This hypothesis was explored with two major Aims. The <italic>first Aim</italic> was to define the role of NOS2 in the activation of mitochondrial biogenesis in the heart of <italic>E. coli</italic>-treated mice. The <italic>second</italic> was to investigate the ability of NOS2 to be transcriptionally regulated by an enzyme previously shown to induce mitochondrial biogenesis, heme oxygenase-1 (HO-1). This hypothesis was tested using an <italic>in vivo</italic> model of sublethal heat-killed <italic>E. coli</italic> (<italic>HkEC</italic>) peritonitis in C57B/L6 (Wt), NOS2-/-, and TLR4-/- mice. Additionally, <italic>in vitro</italic> systems of mouse AML-12 or Hepa 1-6 cells pretreated with HO-1 activators or <italic>Hmox1</italic> shRNA prior to inflammatory challenge with lipopolysaccharide (LPS) +/- tumor necrosis factor-&alpha; (TNF-&alpha;). For the first Aim, Wt, NOS2-/-, and TLR4-/- mice were treated with (<italic>HkEC</italic> and cardiac tissue analyzed for mitochondrial function, expression of nuclear and mitochondrial proteins needed for mitochondrial biogenesis, and histological expression of NOS2 and TLR4 relative to changes in mitochondrial mass. For the second Aim, Wt mice were pretreated with hemin or carbon monoxide (CO) to activate HO-1 prior to <italic>HkEC</italic>-peritonitis. Liver tissue in these animals was evaluated at four hours for HO-1 induction, <italic>Nos2</italic> mRNA expression, cytokine profiles, and nuclear factor (NF)-&kappa;B activation. Liver cell lines were pretreated with hemin, CO-releasing molecule (CORM), or bilirubin one hour before LPS exposure and the <italic>Nos2</italic> transcriptional response evaluated at two and 24 hours. The MTT assay was used to confirm that <italic>in vitro</italic> treatments were not lethal. </p><p>These studies demonstrated that <italic>HkEC</italic> induced mtDNA damage in the heart that was repaired in Wt mice but not in NOS2-deficient mice. In KO mice, sustained mtDNA damage was associated with the reduced expression of nuclear (NRF-1, PGC-1&alpha;) and mitochondrial (Tfam, Pol-&gamma;) proteins needed for mitochondrial biogenesis. The findings thus supported that NOS2 is required for mitochondrial biogenesis in the heart during Gram-negative challenge. Evaluation of the relationship between HO-1 and NOS2 in murine liver was more complex; HO-1 activation in <italic>HkEC</italic>-treated Wt mice attenuated 4-hour <italic>Nos2</italic> gene transcription. In liver cell lines, hemin, CORM, and bilirubin were unable to suppress <italic>Nos2</italic> expression at the time of maximal induction (2 hours). <italic>Nos2</italic> was, however, suppressed by 24 hours, suggesting that the regulatory impact of HO-1 induction was not engaged early enough to reduce <italic>Nos2</italic> transcription at 2 hours. It is concluded that NOS2 induction in bacterial sepsis optimizes the expression of the mitochondrial biogenesis transcriptional program, which subsequently can also be regulated by HO-1/CO in murine liver. This provides a potential new mechanism by which immune suppression and mitochondrial repair can occur in tandem during the acute inflammatory response.</p> / Dissertation
78

Angiotensin II Proteomic Signature in Human Proximal Tubular Cells as a Predictor of Renin Angiotensin System Activity in Kidney Diseases

Konvalinka, Ana 22 July 2014 (has links)
Angiotensin II (AngII), the major effector of the renin angiotensin system, mediates kidney disease progression by signalling through AT-1 receptor (AT-1R), but there are no specific measures of renal AngII activity. Accordingly, we sought to define an AngII-regulated proteome in primary human proximal tubular cells (PTEC) in order to identify potential AngII activity markers in the kidney. We utilized stable isotope labelling with amino acids (SILAC) in PTECs to compare proteomes of AngII-treated and control cells. Of 4618 quantified proteins, 83 were differentially regulated. SILAC ratios for 18 candidates were confirmed by Selected Reaction Monitoring (SRM) assays. Both SILAC and SRM revealed the nuclear factor erythroid 2-related 2 (Nrf2) target protein, heme oxygenase-1 (HO-1) as the most significantly upregulated protein in response to AngII stimulation. AngII-dependent regulation of HO-1 gene and protein was further verified by qRT-PCR and ELISA in PTECs. In order to extend these in vitro observations, we utilized a systems biology approach. We thus overlaid a network of significantly enriched gene ontology (GO) terms from our AngII-regulated proteins with a dataset of differentially expressed kidney genes from AngII-treated wild type mice and AT-1R knock-out mice. Five GO terms were enriched both in vitro and in vivo, and all included HO-1. Furthermore, four additional Nrf2 target proteins were functionally important in vitro and in vivo. We then studied HO-1 kidney expression and urinary excretion in AngII-treated wild type mice and mice with PTEC-specific AT-1R gene deletion. Deletion of the AT-1R gene in PTECs lowered both kidney expression and urine excretion of HO-1, confirming AngII/AT-1R mediated regulation of HO-1. In summary, our in vitro experiments identified novel molecular markers of AngII activity in PTECs and the animal studies demonstrated that these markers also reflect AngII activity in PTECs in vivo. These interesting proteins hold promise as specific markers of renal AngII activity in patients and in experimental models.
79

Regulation of δ-Aminolevulinic Acid Synthase and Heme Oxygenase in Cultured Chick Embryo Liver Cells: Synergistic Induction of Both Enzymes by Glutathimide and Iron and Repression of δ-Aminolevulinic Acid Synthase by Metalloporphyrins and Heme: A Dissertation

Cable, Edward Earl 01 April 1993 (has links)
Primary chick embryo liver cells were used to explore the regulation of δ-aminolevulinic acid synthase and heme oxygenase, the enzymes that catalyze the rate-limiting reactions of heme anabolism and catabolism, respectively. The general focus of the work was the exploration of the novel observation in which glutethimide and iron synergistically induced both δ-aminolevulinic acid synthase and heme oxygenase, a phenomenon that would not be predicted a priori. The course of events appeared to be: first, that heme synthesis was increased after addition of the glutethimide and that iron potentiated heme synthesis; second, the heme induced heme oxygenase five to ten fold; and third, that heme oxygenase degraded the heme permitting an uncontrolled induction of δ-aminolevulinic acid synthase. This induction of δ-aminolevulinic acid synthase could be prevented by the addition of a metalloporphyrin inhibitor of heme oxygenase. Induced δ-aminolevulinic acid synthase activity could be dramatically reduced by the addition of nanomolar concentrations of a metalloporphyrin, inhibitory for heme oxygenase, and heme. Specific observations related to the synergistic induction of heme oxygenase by glutethimide and iron was that the induction of heme oxygenase activity by glutethimide and iron occurred rapidly, with maximal increases occurring four to six hours after original treatment. Induction of heme oxygenase by glutethimide and iron was shown to be dependent on de novoheme synthesis since 4,6-dioxoheptanoic acid, a potent and specific inhibitor of heme biosynthesis, prevented the activity of heme oxygenase from increasing in the presence of glutethimide and iron. Induction of activity was associated with increases in heme oxygenase mRNA and protein; and, when induction was prevented by 4,6-dioxoheptanoic acid, no increase in either mRNA or immunoreactive protein was observed. δ-Aminolevulinic acid synthase activity was also synergistically increased by glutethimide and iron; this increase occurred 4-6 hours after maximal heme oxygenase activity had been attained. The temporal relationship between the induction of δ-aminolevulinic acid synthase and heme oxygenase suggested that the oxygenase depleted a regulatory heme pool that would normally prevent uncontrolled induction of the synthase. When cultures were exposed to tin-mesoporphyrin, a potent inhibitor of heme oxygenase, induction of δ-aminolevulinic acid synthase, normally produced by glutethimide and iron, was prevented. Addition of tin-mesoporphyrin after δ-aminolevulinic acid synthase induction had already been established promptly halted any further induction. When heme or a combination of heme and tin-mesoporphyrin was added after induction of δ-aminolevulinic acid synthase was established, activity of the synthase was rapidly reduced. Finally, experiments in primary chick embryo liver cells with tin-, zinc- and copper- chelated porphyrins were done to assess their effects on activities of δ-aminolevulinic acid synthase, induced by prior treatment of cells with glutethimide and iron. Nanomolar concentrations of zinc- or tin porphyrins reduced δ-aminolevulinic acid synthase activities, while copper-chelated porphyrins did not. When nanomolar concentrations of heme were added with zinc- or tin-porphyrins, δ-aminolevulinic acid synthase activity was further reduced. Effects of the non-heme metalloporphyrins on δ-aminolevulinic acid synthase were closely correlated with their abilities to inhibit heme oxygenase (r=0.78). The largest decrease of δ-aminolevulinic acid synthase (67%) was obtained with zinc-mesoporphyrin and heme. There was a rapid appearance of the cytosolic, precursor form of δ-aminolevulinic acid synthase in the presence of both 10 μM heme or 50 nM zinc-mesoporphyrin and 200 nM heme. Reduction of the half-life of the mRNA from 5.2 hours to 2.2-2.5 hours was observed in the presence of both 10 μM heme or 50 nM zinc-mesoporphyrin and 200 nM heme. In summary, the chick embryo liver cell culture model treated with glutethimide and iron may serve as one experimental model for patients suffering from acute porphyrias, in whom uncontrolled induction of hepatic δ-aminolevulinic acid synthase plays a key role in pathogenesis of disease. The synergistic induction of δ-aminolevulinic acid synthase in the presence of glutethimide and iron may serve as an experimental paradigm for this disease. The reduction of δ-aminolevulinic acid synthase by low doses of zinc-mesoporphyrin and heme may help form the experimental foundation for eventual studies in patients suffering from acute porphyrias.
80

Papel da proteína heme oxigenase 1 na infecção de macrófagos por leishmania chagasi

Luz, Nívea Farias January 2011 (has links)
Submitted by Ana Maria Fiscina Sampaio (fiscina@bahia.fiocruz.br) on 2012-08-01T21:22:36Z No. of bitstreams: 1 Nivea Farias Luz Papel da proteína hemeoxigenase....pdf: 1624634 bytes, checksum: 6f830105c144bc3c799743a490e5a511 (MD5) / Made available in DSpace on 2012-08-01T21:22:36Z (GMT). No. of bitstreams: 1 Nivea Farias Luz Papel da proteína hemeoxigenase....pdf: 1624634 bytes, checksum: 6f830105c144bc3c799743a490e5a511 (MD5) Previous issue date: 2011 / Fundação Oswaldo Cruz. Centro de Pesquisas Gonçalo Moniz. Salvador, Bahia, Brasil / A leishmaniose visceral (LV) apresenta ampla distribuição geográfica e é fatal caso não seja tratada. As manifestações hematológicas são constantes na LV e em casos não tratados os pacientes evoluem à óbito por sangramento maciço ou anemia grave. Neste cenário, mecanismos ligados à hemólise, metabolismo do heme e atividade da enzima heme oxigenase podem estar envolvidos na imunopatogênese da LV, no entanto essa perspectiva ainda não foi explorada. A heme oxigenase (HO) tem importantes propriedades regulatórias e está envolvida em processos fisiológicos e patofisiológicos como citoproteção e inflamação. Apesar de sua sugestiva participação no contexto da infecção por Leishmania, uma rápida pesquisa no PubMed com as palavras heme oxigenase e Leishmania remete a somente três trabalhos até a presente data. Nesse projeto testaremos a hipótese de que a ativação da enzima heme oxigenase-1 (HO-1) favorece a infecção por Leishmania (L) chagasi, principal agente etiológico da LV humana no Brasil. Nossas observações nesse trabalho indicam que a enzima HO-1 é induzida em macrófagos durante a infecção por L. chagasi e que a indução farmacológica da HO-1, pela CoPP aumenta a carga parasitária de macrófagos infectados por L. chagasi e reduz a produção de mediadores pró-inflamatórios frente à estimulação por LPS, tais como TNF, NO, PGE2, MCP-1, IL-1β e IL-6. Além disso, a HO-1 favorece um ambiente anti-inflamatório onde prevalece a presença de IL-10 sobre a de TNF. Macrófagos derivados de medula óssea de camundongos deficientes no gene HO-1 tem menor carga parasitária, quando infectados por L. chagasi em comparação aos macrófagos de camundongos selvagens. Esses achados indicam um potencial deletério para a HO-1 na infecção por L. chagasi, bem como sugerem possíveis mecanismos envolvidos na imunopatogênese da LV. / Visceral leishmaniasis (VL) is a widespread disease and is fatal if left untreated. Hematological manifestations are common in VL and untreated patients evolve to death from massive bleeding and severe anemia. In this scenario, mechanisms related to hemolysis, heme metabolism and enzyme activity of heme oxygenase may be involved in the immunopathogenesis of VL. But that panorama has not been explored. Heme oxygenase (HO) has important regulatory properties and is involved in patho-physiological processes such as cytoprotection and inflammation. Despite HO participation in the context of Leishmania infection is suggestive, a quick search on PubMed with the words heme oxygenase and Leishmania refers to only three papers to date. This project will test the hypothesis that heme oxygenase- 1 (HO-1) activation favors Leishmania (L) chagasi, the main etiology agent of human VL in Brazil. Our observations indicate that HO-1 is induced in macrophages during L. chagasi infection and pharmacological induction of HO-1 by CoPP increases parasite load of infected macrophages and results in inhibition of TNF- α, IL-1β, IL-6, MCP-1, PGE2 and Nitrite levels upon LPS stimulation and simultaneously induced a higher IL-10/TNF-α ratio in peritoneal macrophages contributing to the anti inflammatory pathway that favors L. chagasi replication. Beyond this, we observed that bone marrow derived macrophages knockout to HO-1 gene have a significant low parasite load when infected by L. chagasi than their wild type counterparts. In summary, our findings suggest that this enzyme can play a deleterious role in VL and clarify one of the immunoregulatory mechanisms involved in VL.

Page generated in 0.0711 seconds